H3N2 is a subtype of seasonal influenza that can be serious, especially for older adults, young children, pregnant people, and those with chronic conditions. It often causes more severe seasons and can lead to complications such as pneumonia, hospitalization, and death. Annual vaccination, early antiviral treatment when indicated, and good hygiene reduce risk and severity.

Yes. Influenza A ranges from mild to life‑threatening; it causes seasonal epidemics and can lead to complications such as viral or secondary bacterial pneumonia, hospitalization, and death, especially in infants, older adults, pregnant people, and those with chronic illnesses or weakened immunity. Antiviral treatment and yearly vaccination reduce severity and complications. Seek care for high fever, difficulty breathing, dehydration, or worsening symptoms.

Influenza A subtype H3N2 is a seasonal flu virus defined by H3 hemagglutinin and N2 neuraminidase surface proteins. It mutates frequently (antigenic drift), causing yearly outbreaks and sometimes severe illness in older adults, young children, and people with chronic conditions. Spread is by respiratory droplets; symptoms include fever, cough, body aches, and fatigue. Annual vaccination and early antiviral treatment reduce risk and complications.

Influenza A is a genus of influenza viruses in the Orthomyxoviridae family that causes seasonal flu and occasional pandemics. It infects humans and many animals (birds, pigs) and is classified by surface proteins hemagglutinin (H) and neuraminidase (N) into subtypes like H1N1 or H3N2. Influenza A shows frequent antigenic drift and shift, enabling rapid evolution and zoonotic transmission.

COVID-19 is generally worse than influenza A for most people: it has caused higher rates of hospitalization, intensive care needs and death, can produce prolonged symptoms (long COVID), and strains healthcare systems more. Influenza A still causes significant illness and deaths yearly, especially in older or immunocompromised people. Vaccination, early treatment and public-health measures reduce severity for both.

H3N2 generally causes worse seasons, producing more hospitalizations and deaths—especially among older adults—while H1N1 more often affects younger people and typically causes less overall severe illness. Vaccine effectiveness varies by season and strain; annual influenza vaccination, good hand hygiene, and prompt antiviral treatment for high-risk individuals reduce the risk of complications and severity.